Subramanian Swamy Calls for Ban on Cement Imports from Pakistan Citing Security Risks MuskAltman Trial Reveals AI Sectors Inner Workings Industry Emerges as Key Beneficiary BofA Adjusts Royal Gold Price Target Amid Reduced Hod Maden Stake Traders Skeptical of Irans Timeline for Strait of Hormuz Reopening US Pentagon Releases Decades of UFO Sighting Reports Detailing Orbs Swarming in All Directions Maines Groundfishing Industry Faces Inflation Squeeze Free Fillet Program Offers Potential Lifeline AGPU Q1 2025 Earnings Deep Losses and Uncertainty Weigh on Shares After Major EPS Miss Immunome Inc IMNM Q1 2026 Earnings SmallerThanExpected Loss as Biotech Advances Pipeline QVCGP Q3 2025 Earnings Preferred Stock Reports Significant Loss per Share Amid Retail Headwinds Newmark Group Inc NMRK Q1 2026 Earnings EPS Surprises to the Upside Shares Edge Higher SUPV Q1 2026 Earnings Stellar Earnings Surprise as EPS Beats Estimates by Wide Margin RLI Corp Q1 2026 Earnings EPS Surpasses Estimates Shares Dip Slightly Flanigans Enterprises BDL Bounces Higher Support Holds Amid Modest Gains NOV Inc Shows Modest Gains as Stock Hovers Near Support Levels TriMas Corporation TRS Holds Gains Near Resistance After 26 Rally McKinley Acquisition Rights MKLYR Slips 33 as Price Nears Key 013 Floor Saratoga Investment Corp New SAR Holds Steady at 2223 Key Levels in Focus ALZN Q1 2026 Earnings EPS Surprise of 7046 as Loss Narrows Sharply from Analyst Expectations Marten Transport Q1 2026 Earnings Small EPS Beat Amidst Challenging Freight Environment LVWR Q1 2026 Earnings Narrowing Losses as Electric Motorcycle Pioneer Pivots to Growth BCE Q1 2026 Earnings EPS Beat Drives Modest Stock Uptick Comstock Inc LODE Q1 2026 Earnings EPS Surpasses Estimates Despite Lack of Revenue Mustang Bio Inc MBIO Q4 2024 Earnings Severe EPS Miss Highlights PreRevenue Biotech Challenges TikTok Goes Dark Trump Signals Potential Intervention as App Remains Unavailable OSCR Q1 2026 Earnings Massive EPS Beat Highlights Insurers Profitability TurnStock Dips Despite Strong Results Halozyme Therapeutics HALO Holds Above Key Support as Selling Pressure Eases